Technical Analysis for ROSGQ - Rosetta Genomics Ltd

Grade Last Price % Change Price Change
grade F 0.0041 -54.44% -0.0049
ROSGQ closed down 54.44 percent on Tuesday, January 21, 2020, on 74 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical ROSGQ trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
200 DMA Support Bullish -54.44%
20 DMA Support Bullish -54.44%
Older signals for ROSGQ ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Rosetta Genomics Ltd. operates as a genomic diagnostics company worldwide. The company's microRNA technologies based diagnostic tests include RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer; mi-KIDNEY, a kidney tumor classification test for pathology samples; RosettaGX Reveal for the diagnosis of indeterminate thyroid fine-needle aspirate samples; and mi-LUNG diagnostic tests. It also provides UroVysion, a urine-based Fluorescence In Situ Hybridization (FISH) assay that is intended for use in conjunction with and not in lieu of current standard diagnostic procedures, as an aid for initial diagnosis of bladder carcinoma in patients with hematuria and subsequent monitoring for tumor recurrence in patients previously diagnosed with bladder cancer; and ERG/PTEN, which are FISH-based prognostic tests in prostate cancer. In addition, the company offers ALK/ROS1 that are FISH-based predictive tests indicated for patients who are diagnosed with late stage lung cancer; and PCR gene mutation analysis for bladder, lung, colon, and melanoma patients. The company provides its diagnostic solutions for oncologists, urologists, endocrinologists, cytopathologists, and other specialists to facilitate them in serving their patients. It has a license agreement with Max Planck Innovation GmbH for the rights to its proprietary microRNAs for diagnostics and research purposes. The company also has a collaboration agreement with Meir Medical Center to develop a microRNA classifier relating to patients with non-small cell lung cancer considered for treatment with immuno oncology drugs. Rosetta Genomics Ltd. was founded in 2000 and is headquartered in Rehovot, Israel.
RTT Branches Of Biology Cancer Oncology Tumor Prostate Cancer Diagnostic Tests Non Small Cell Lung Cancer Melanoma Bladder Cancer Infectious Causes Of Cancer Genetics Metastatic Cancer Non Small Cell Lung Carcinoma Hybridization Ros1 Diagnostic Solutions

Is ROSGQ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News


Indicator Value
52 Week High 0.0336
52 Week Low 0.0001
Average Volume 21,592
200-Day Moving Average 0.0053
50-Day Moving Average 0.0049
20-Day Moving Average 0.0052
10-Day Moving Average 0.0063
Average True Range 0.0037
ADX 47.32
+DI 34.8515
-DI 18.6139
Chandelier Exit (Long, 3 ATRs ) -0.0011
Chandelier Exit (Short, 3 ATRs ) 0.0132
Upper Bollinger Band 0.0109
Lower Bollinger Band -0.0005
Percent B (%b) 0.4
BandWidth 219.2308
MACD Line 0.0007
MACD Signal Line 0.0005
MACD Histogram 0.0003
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0077
Resistance 3 (R3) 0.0081 0.0073 0.0071
Resistance 2 (R2) 0.0073 0.0064 0.0071 0.0069
Resistance 1 (R1) 0.0057 0.0058 0.0053 0.0053 0.0067
Pivot Point 0.0049 0.0049 0.0047 0.0047 0.0049
Support 1 (S1) 0.0033 0.0040 0.0029 0.0029 0.0015
Support 2 (S2) 0.0025 0.0034 0.0023 0.0013
Support 3 (S3) 0.0009 0.0025 0.0011
Support 4 (S4) 0.0005